M&A Deal Summary |
|
|---|---|
| Date | 2014-08-14 |
| Target | Questcor Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Mallinckrodt |
| Deal Type | Add-on Acquisition |
| Deal Value | 5.8B USD |
| Advisor(s) | Centerview Partners (Financial) Latham & Watkins Matheson Keys & Kordzik PLLC (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1867 |
| Sector | Life Science |
| Employees | 2,673 |
| Revenue | 2.2B USD (2021) |
Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. Mallinckrodt was founded in 1867 and is based in Dublin, Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 12 |
| Sector (Life Science) | 2 of 9 |
| Type (Add-on Acquisition) | 4 of 10 |
| State (California) | 2 of 3 |
| Country (United States) | 4 of 11 |
| Year (2014) | 2 of 2 |
| Size (of disclosed) | 1 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-11 |
Cadence Pharmaceuticals
San Diego, California, United States Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. |
Buy | $1.3B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-16 |
Ikaria
Clinton, New Jersey, United States Ikaria is a critical care therapeutics company. Ikaria is based in Clinton, New Jersey. |
Buy | $2.3B |
